# Corporate executive stock liquidations

> Live situation record from CLSTR: https://clstr.news/situations/corporate-executive-stock-liquidations
> Updated: 2026-09-29T23:08:07.000Z. Sources: 3. Developments: 2.

Reports indicate a series of significant stock liquidations by corporate executives across various industries. These transactions are frequently conducted under pre-arranged Rule 10b5-1 trading plans.

In late August, executives at Xeris Biopharma Holdings, Inc., including the CFO, Chief Legal Officer, and COO, sold a combined total of over $300,000 in stock. Despite these sales, the executives maintained substantial direct ownership in the company.

By late September, the scale of executive stock sales expanded to include multi-million dollar transactions. Notable liquidations included Marc Boroditsky of Nebius Group N.V., who sold approximately $1.5 million in shares, and Xiaodong Wang of BeOne Medicines Ltd., who sold over $11.3 million in shares, representing a 50% decrease in his position. Other reported sales involved executives from Cerebras Systems Inc., EOG Resources, Inc., and Abeona Therapeutics Inc.

## Timeline

### 2026-09-29: Corporate executives execute multi-million dollar stock sales

Multiple corporate executives from companies including Nebius Group, Cerebras Systems, EOG Resources, Abeona Therapeutics, and BeOne Medicines have reported significant stock sales via SEC filings.

2 sources. https://clstr.news/cluster/corporate-executives-execute-multi-million-dollar-stock-sales

### 2026-08-31: Xeris Biopharma executives sell over $300,000 in stock

Top executives at Xeris Biopharma, including the CFO, COO, and Chief Legal Officer, sold over $300,000 in stock via automated trading plans on September 1.

2 sources. https://clstr.news/cluster/xeris-biopharma-executives-sell-over-300000-in-stock

---
Cite as: Corporate executive stock liquidations. CLSTR, https://clstr.news/situations/corporate-executive-stock-liquidations